Financial Summary (All financials)
In millions, except per share items | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 |
Revenues | 129.0 | 100.3 | 89.2 | 44.4 | 25.9 | 14.9 | 13.8 |
Revenue growth | 28.6% | 12.5% | 100.7% | 71.7% | 73.8% | 8.0% | |
Cost of goods sold | 32.7 | 24.1 | 24.3 | 11.1 | 8.9 | 5.4 | 8.1 |
Gross profit | 96.3 | 76.3 | 64.9 | 33.3 | 17.0 | 9.5 | 5.7 |
Gross margin | 74.6% | 76.0% | 72.7% | 75.1% | 65.7% | 63.7% | 41.3% |
Selling, general and administrative | 61.4 | 44.7 | 40.7 | 21.5 | 12.1 | 10.1 | 15.1 |
Research and development | 4.5 | 3.9 | 2.8 | 1.0 | 0.6 | 0.7 | 1.8 |
EBIT | 18.2 | 12.9 | 10.6 | 7.2 | 1.7 | -3.9 | -14.2 |
EBIT margin | 14.1% | 12.9% | 11.9% | 16.1% | 6.6% | -26.3% | -103.1% |
Pre-tax income | 19.5 | 12.5 | -81.7 | 6.1 | 1.8 | -3.0 | -17.3 |
Income taxes | 6.6 | 4.0 | -15.8 | 0.4 | 0.2 | -0.6 | 0.0 |
Tax rate | 33.7% | 32.2% | 19.3% | 6.7% | 8.3% | 19.2% | 0.0% |
Net income | 12.9 | 8.5 | -66.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | 10.0% | 8.4% | -74.0% | -0.1% | 0.0% | 0.0% | -0.1% |
|
Diluted EPS | $478.57 | $328.98 | ($2,723.67) | ($2.70) | $0.06 | ($6.42) | ($18.08) |
Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|